HeartSciences merges with Fortitude
- Definitive merger agreement signed
- All-stock transaction
- Filing date: 2026-10-15
HSCSW
HeartSciences Inc. SEC filings
Every EDGAR filing for HeartSciences Inc. (HSCSW), newest first, with AI summaries and stories.
- Ticker
- HSCSW
- CIK
- 1468492
- Sector
- Financial services and asset managers
- Latest filing
- 3d
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINE424B5HeartSciences Inc.HSCSWLIVE HeartSciences Inc. increases stock offering limit
- Up to $4,161,139 in common stock offered
- Previously sold 1,529,287 shares for $14.1 million
- Amendment increases maximum offering limit
ROUTINE8-KHeartSciences Inc.HSCSWLIVE HeartSciences gets FDA clearance for MyoVista device
- FDA granted 510(k) clearance (K260005) for MyoVista wavECG device
- Clearance covers ECG signal acquisition and interpretation for adult and pediatric patients
- Device does not include AI-ECG algorithm
ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE HeartSciences gets FDA clearance for MyoVista device
- FDA granted 510(k) clearance (K260005) for MyoVista wavECG device
- Clearance covers ECG signal acquisition and interpretation for adult and pediatric patients
- Device does not include AI-ECG algorithm
ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE HeartSciences Inc. announces merger with Fortitude
- Definitive merger agreement signed on 2026-10-06
- All-stock transaction expected to make Fortitude public
- Fortitude secures $100M non-binding equipment purchase commitment
ROUTINEPRER14AHeartSciences Inc.HSCSWLIVE HeartSciences Inc. announces merger plans
- Merger with Fortitude Seller on 2026-10-06
- Exchange Ratio based on HeartSciences stock price
- Fortitude Seller to receive Class V Common Stock
ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE HeartSciences extends loan maturity
- Loan maturity extended to Jan 29, 2027
- Accrued interest due by Sep 30, 2026
- Company can repay $50k+ anytime before maturity
ROUTINE8-KHeartSciences Inc.HSCSWLIVE HeartSciences extends loan maturity
- Loan maturity extended to Jan 29, 2027
- Interest rate 12% annually
- Amendment No. 8 signed Sep 29, 2026
ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINES-3HeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEPRER14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINE8-KHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINE8-KHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE NOTABLE10-QHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINES-8HeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINE8-KHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINE8-K/AHeartSciences Inc.HSCSWLIVE ROUTINEDEFA14AHeartSciences Inc.HSCSWLIVE ROUTINE8-KHeartSciences Inc.HSCSWLIVE NOTABLESCHEDULE 13DHeartSciences Inc.HSCSWLIVE Ownership stake disclosure by Digital Currency Group, Inc.
Digital Currency Group, Inc., filed by